title: Reply: Personalized Antiplatelet Therapy: The Odyssey Continues.
authors.forename: Renato
authors.initials: R
authors.lastname: Valenti
authors.forename: David
authors.initials: D
authors.lastname: Antoniucci
mesh_terms: D003324:Coronary Artery Disease / Q000628:therapy*; D003328:Coronary Thrombosis / Q000517:prevention & control*; D057915:Drug Substitution; D005260:Female; D006801:Humans; D008297:Male; D062645:Percutaneous Coronary Intervention / Q000295:instrumentation*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D000068799:Prasugrel Hydrochloride / Q000008:administration & dosage*; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010975:Platelet Aggregation Inhibitors; D000068799:Prasugrel Hydrochloride; D013988:Ticlopidine